NLS Science News

Sir Demis Hassabis, co-founder and CEO of Google DeepMind and Isomorphic Labs, and John Jumper, Director and Senior Research Scientist at Google DeepMind, have been honored with the 2024 Nobel Prize in Chemistry for their revolutionary technology for predicting the 3D structure of proteins.

David Baker, born in Seattle in 1962, is an American professor of biochemistry and computational biology at the University of Washington, Seattle, and Howard Hughes Medical Institute. He has received the Nobel Prize in Chemistry for his pioneering research methods in protein design, and NLS asked him about his career, being a scientist, and of course, a lot about proteins.


Victor Ambros, Professor of Molecular Medicine and the Silverman Chair in Natural Sciences at the University of Massachusetts Chan Medical School, is one of this year’s winners of the Nobel Prize in Physiology or Medicine.

More than three decades after their discovery of microRNA, Professor Gary Ruvkun received the “mythic call” from Stockholm to learn that he’d been awarded the Nobel Prize in Physiology or Medicine alongside his erstwhile colleague Victor Ambros.

When it comes to life science, one of the strengths of Norway and the Nordics is basic and translational immunology. This is where researchers engineer cells and soluble proteins with the aim of developing new strategies to treat diseases, such as autoimmunity and cancer. 

The Nobel Prize in Chemistry 2024 recognizes both computational protein design and protein structure prediction.

The 2024 Nobel Prizes in Chemistry and Physics reflect the revolutionary impact of artificial intelligence (AI) on life sciences. These awards, celebrating advancements in protein design and neural networks, demonstrate how AI is transforming how we approach drug discovery, personalized medicine, and healthcare management.

The Nobel Prize in Physiology or Medicine 2024 recognizes the discovery of microRNA and its role in post-transcriptional gene regulation.